Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KYNTRA BIO, INC.
Report date September 07, 2021 · Filed September 10, 2021
Section 16 reporting ended · disclosed 2021-09-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 274,536 |
Reported balance
After 2021-09-07 transaction · row 1
1 source rowRow 1 · 2021-09-07 · Tax withholding · Disposed 2,141 · Balance 274,536 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 07, 2021 Filed Sep 10, 2021 01:35 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,141 | $12.41 | $26,569.81 |
DisclosureSEC source: 0001209191-21-055405 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · Executive Advisor & Former CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,536 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 01:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 4,053 | $25.62 | $103,837.86 |
DisclosureSEC source: 0001209191-21-041808 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,677 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,141 | $22.90 | $49,028.90 |
DisclosureSEC source: 0001209191-21-039294 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,730 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 684 shares acquired on May 14, 2021 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 22:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 5,657 | $33.37 | $188,774.09 |
DisclosureSEC source: 0001209191-21-019551 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,187 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 41,700 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001209191-21-015009 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,700 Underlying: Common Stock · 41,700 shares Expires 2031-02-24 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 21,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015009 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,844 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:04 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,068 | $43.60 | $133,764.80 |
DisclosureSEC source: 0001209191-20-064227 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,144 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,014 | $41.99 | $126,557.86 |
DisclosureSEC source: 0001209191-20-062617 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,212 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 22:03 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,070 | $43.63 | $133,944.10 |
DisclosureSEC source: 0001209191-20-050998 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,226 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 23:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,014 | $42.16 | $127,070.24 |
DisclosureSEC source: 0001209191-20-050048 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,296 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,671 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,579 Underlying: Common Stock · 8,671 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,696 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · derivative · entry 6 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,696 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 637 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · derivative · entry 5 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,618 Underlying: Common Stock · 637 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 15,004 | $50.91 | $763,853.64 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,310 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $50.89 to $51.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 8,671 | $25.40 | $220,243.40 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,696 | $19.39 | $110,445.44 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 637 | $29.66 | $18,893.42 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2024-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · derivative · entry 6 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,696 Underlying: Common Stock · 3,750 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 3,500 | $18.00 | $63,000.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 3,750 | $19.39 | $72,712.50 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 20:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,554 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · derivative · entry 5 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,446 Underlying: Common Stock · 22,554 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 20:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 22,554 | $48.00 | $1,082,592.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,060 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 20:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 22,554 | $19.39 | $437,322.06 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 22:35 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,928 | $39.68 | $155,863.04 |
DisclosureSEC source: 0001209191-20-037710 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,060 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:47 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,156 | $33.61 | $72,463.16 |
DisclosureSEC source: 0001209191-20-035697 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,988 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 678 shares acquired on May 15, 2020 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 66,250 | $0.00 Strike: $26.41 | $0.00 |
DisclosureSEC source: 0001209191-20-020120 · doc4.xml · derivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,250 Underlying: Common Stock · 66,250 shares Expires 2030-03-17 F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020120 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,466 F3 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 9,239 | $26.36 | $243,540.04 |
DisclosureSEC source: 0001209191-20-020120 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,466 F2 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| March 06, 2020 Filed Mar 19, 2020 00:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 4,881 | $39.71 | $193,824.51 |
DisclosureSEC source: 0001209191-20-020120 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,705 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,254 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-19-061939 · doc4.xml · derivative · entry 8 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,254 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Optin (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-19-061939 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires 2022-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-19-061939 · doc4.xml · derivative · entry 6 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires 2021-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 12,729 | $46.27 | $588,970.83 |
DisclosureSEC source: 0001209191-19-061939 · doc4.xml · nonDerivative · entry 5 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,586 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $45.91 to $46.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 46,727 | $45.51 | $2,126,545.77 |
DisclosureSEC source: 0001209191-19-061939 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,315 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $44.91 to $45.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 17,254 | $14.58 | $251,477.05 |
DisclosureSEC source: 0001209191-19-061939 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 21,000 | $5.95 | $124,950.00 |
DisclosureSEC source: 0001209191-19-061939 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 18,000 | $3.50 | $63,000.00 |
DisclosureSEC source: 0001209191-19-061939 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 01:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,144 | $47.39 | $148,994.16 |
DisclosureSEC source: 0001209191-19-059777 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,788 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 02:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-19-056233 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 02:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 12,500 | $2.90 | $36,250.00 |
DisclosureSEC source: 0001209191-19-056233 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 18, 2019 23:42 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,201 | $41.38 | $132,457.38 |
DisclosureSEC source: 0001209191-19-050167 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,432 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 06, 2019 Filed Sep 11, 2019 00:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,144 | $41.68 | $131,041.92 |
DisclosureSEC source: 0001209191-19-049098 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,633 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,201 | $43.12 | $138,027.12 |
DisclosureSEC source: 0001209191-19-038294 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,777 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 23:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,144 | $38.31 | $120,446.64 |
DisclosureSEC source: 0001209191-19-035676 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,978 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 618 shares acquired on May 15, 2019 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 06, 2019 Filed May 8, 2019 22:45 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-19-028336 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 7,000 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 06, 2019 Filed May 8, 2019 22:45 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 7,000 | $2.90 | $20,300.00 |
DisclosureSEC source: 0001209191-19-028336 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 00:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-19-025182 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 10,000 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 00:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 10,000 | $2.90 | $29,000.00 |
DisclosureSEC source: 0001209191-19-025182 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 22:47 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 7,665 | $55.41 | $424,717.65 |
DisclosureSEC source: 0001209191-19-020671 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,504 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.